AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)
$1.07 0.04 (3.8835%)
Analysed AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) News Sources
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology
04-05-2026
yahoo.com
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04-05-2026
yahoo.com
United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates
06-05-2026
yahoo.com
Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights
07-05-2026
yahoo.com
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
Akebia Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Akebia (AKBA) Q1 2026 Earnings Transcript
08-05-2026
fool.com
Analysts Are Updating Their Akebia Therapeutics, Inc. (NASDAQ:AKBA) Estimates After Its First-Quarter Results
11-05-2026
yahoo.com
Promising Penny Stocks To Consider In May 2026
26-05-2026
yahoo.com
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
What is the current price of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The current price of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is $1.07.
AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) absolute price change since previous trading day?
The absolute price change of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) since the previous trading day is $0.04.
AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) percentage price change since previous trading day?
The percentage price change of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) since the previous trading day is 3.8835%.
What is the most recent average sentiment score for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The most recent average sentiment score for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The most recent sentiment for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is .
SEC-8K** Filing Available For AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.